Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

Source link

Related posts

NAFLD — sounding the alarm on a silent epidemic


Adipogenesis and metabolic health


New Treatment for Ulcerative Colitis Approved


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy